Own Pain Relief Solution Store In Your City | Franchise Sales & Distribution Call us on 8691006638
Unfractionated heparin remains a fundamental component in anticoagulant therapy, particularly in hospital and critical care settings where rapid and controllable anticoagulation is required. It plays a key role in preventing and managing thromboembolic conditions across a wide range of clinical scenarios.
BARIHEP® (Heparin Sodium Injection) is developed by RAWIA INTERNATIONAL HEALTHCARE (RIHCA) in collaboration with leading pharmaceutical manufacturing partners and marketed through RAWIACARE. The 5000 IU strength is widely used for prophylactic anticoagulation and routine clinical applications, supporting healthcare professionals in delivering safe and effective patient care across regional and international healthcare markets — To Share • To Care • To Inspire.
BARIHEP® 5000 IU (Heparin Sodium Injection) is an unfractionated heparin (UFH) indicated for prophylactic anticoagulation and routine clinical use. It works by enhancing antithrombin activity, thereby inhibiting clot formation and supporting stable blood circulation.
This strength is commonly used in hospitals for thromboprophylaxis, catheter maintenance, and dialysis procedures, providing controlled anticoagulant support under medical supervision.
| Specifications Table | |
| Parameter | Details |
| Brand Name | BARIHEP® |
| Generic Name | Heparin Sodium |
| Arabic Name | باريهيب هيبارين صوديوم |
| Category | Anticoagulants |
| Therapeutic Area | Unfractionated Heparin |
| Dosage Form | Injection |
| Strength | 5000 IU |
| Volume | 5 ml |
| Route / Type | Injectable |
| Developed By | RIHCA |
| Platform Name | RAWIACARE / RAWIACARE GLOBAL |
| Prevention of Deep Vein Thrombosis (DVT) |
| Anticoagulation during dialysis |
| Catheter patency maintenance |
| Hospital-based anticoagulant protocols |
| General thromboprophylaxis |
| It is used for preventive anticoagulation, dialysis procedures, and maintaining catheter patency. |
| It enhances antithrombin activity, preventing clot formation and supporting blood flow. |
| It is commonly used in routine hospital settings for prophylactic anticoagulation. |
| Administered via injection under medical supervision. |
| 5000 IU, 10000 IU, 25000 IU |
